No profile data available.
Bone Biologics Corporation (BBLG) is a healthcare company in the bone and joint treatment equipment industry, based in Burlington, United States, with about 2 full-time employees.
It reported revenue of $0 for fiscal year 2024, and net income of -$7.32 million. In Q3 2025 (the quarter ended September 30, 2025) revenue was $0. Its market capitalization was $1.29 million as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2024; market data as of October 9, 2026.
Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein in the United States. Its lead product is NELL-1/DBM medical device, an osteopromotive recombinant protein, which provides target specific control over bone regeneration.
Bone Biologics reported $0 in revenue for fiscal year 2024. In Q3 2025 revenue was $0.
$1.29 million as of October 9, 2026.
Listed companies of a similar size in the same industry (bone and joint treatment equipment) include Tenon Medical, Inc. (TNON), BioElectronics Corporation (BIEL), Stimcell Energetics Inc. (STME), Electromedical Technologies, Inc. (EMED).